Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
PDD:NAS is now under Algo Engine buy conditions. The company is China’s largest agriculture and interactive commerce platform.
Pinduoduo has surpassed Alibaba as China’s largest e-commerce company with 788 million active users according to its latest quarterly earnings report.
We expect buying interest to build above the $125 support level. Q121 earnings should show continued growth.
SNAP:NYS is under Algo Engine buy conditions following the entry signal at $48 in late March.
The stock price jumped a further 7.5% in Friday’s session, after the company reported accelerating revenue growth and strong user numbers during the first quarter.
Q2 2021 Outlook
Revenue is estimated to be between $820 million and $840 million, compared to $454 million in Q2 2020.
Adjusted EBITDA is estimated to be between $(20) million and break-even, compared to $(96) million in Q2 2020.
PDD:NAS is now under Algo Engine buy conditions. The company is China’s largest agriculture and interactive commerce platform.
We expect buying interest to build above the $125 support level. Q121 earnings should show continued growth.
Amcor is under Algo Engine buy conditions. We expect buying support to hold above $15.00.
Investors may consider selling out-of-the-money call options to enhance the income.
OSH:ASX is now under Algo Engine buy conditions.
1Q21 production was ahead of guidance and we now move Oil Search into our top 3 energy plays, along with Beach & Woodside.
CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.
CIMIC is a high risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.
24/4 CIMIC breaks above the 10-day average after forming a new trend low mid-week at $16.86.
WPL:ASX is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.
CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.
ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.
.
ASX:IZZ is under Algo Engine buy conditions. We expect buying interest to increase near the $60 support level.
Buy IZZ at market.
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Or start a free thirty day trial for our full service, which includes our ASX Research.